22 April 2026
Interview with the ECCO Global Taskforce

Fernando Magro, ECCO President
Inflammatory Bowel Disease (IBD) is now evolving as a global condition with rising incidence across all regions of the world. We are attempting to gain a deeper understanding of this new global evolution of IBD, but in addition coordinated global efforts are needed to address disparities in care, access and implementation of best practices.As a well-established organisation with global membership, strong scientific leadership, educational programmes and widely recognised guidelines, ECCO is fully committed to contributing to this global initiative.




